Date Field | Doc. No. | Party | Description |
---|
Jan 31, 2017 | 1 | | PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. 311-319 AND 37 C.F.R. 42 Download |
Jan 31, 2017 | 2 | | Petitioner's Signed Power of Attorney Download |
Feb 21, 2017 | 3 | | Patent Owner's Power of Attorney Download |
Feb 21, 2017 | 4 | | Patent Owner's Mandatory Notices Download |
Feb 24, 2017 | 5 | | Notice of Accord Filing Date Download |
Feb 27, 2017 | 6 | | Patent Owner's Updated Mandatory Notices Download |
Mar 17, 2017 | 7 | | Patent Owner's Second Updated Mandatory Notices Download |
Mar 23, 2017 | 8 | | Petitioner's Updated Mandatory Notices Download |
Apr 7, 2017 | 9 | | Petitioner's Unopposed Motion to Dismiss Petitions Without Prejudice Download |
Apr 7, 2017 | 10 | | Order Conduct of the Proceeding Download |
Apr 11, 2017 | 11 | | Termination Decision Document Download |
May 25, 2017 | 12 | | PETITIONER'S REQUEST FOR REFUND OF POST-INSTITUTION FEES Download |
Jun 5, 2017 | 13 | | Notice of Refund Download |
Jan 31, 2017 | 1201 | | U.S. Patent No. 9,085,619 Download |
Jan 31, 2017 | 1202 | | Declaration of Klaus-Peter Radtke, Ph.D. Download |
Jan 31, 2017 | 1203 | | U.S. Pub. No. 2016/0319011 Download |
Jan 31, 2017 | 1204 | | U.S. App. 60/690,582 Download |
Jan 31, 2017 | 1205 | | HUMIRA Label (Jan. 2003) Download |
Jan 31, 2017 | 1206 | | HUMIRA Label (Jan. 2008) Download |
Jan 31, 2017 | 1207 | | Declaration of David D. Sherry, M.D. Download |
Jan 31, 2017 | 1208 | | Adalimumab Product Approval Information Download |
Jan 31, 2017 | 1209 | | AbbVie Biotechnology Ltd., Annex A - The Humira Story Download |
Jan 31, 2017 | 1210 | | U.S. Pub. No. 2003/0206898 Download |
Jan 31, 2017 | 1211 | | Parslow 1997 Download |
Jan 31, 2017 | 1212 | | Butler & Hamilton 1991 Download |
Jan 31, 2017 | 1213 | | Jefferis et al. 1995 Download |
Jan 31, 2017 | 1214 | | McDonnell 2015 Download |
Jan 31, 2017 | 1215 | | Christensen 1966 Download |
Jan 31, 2017 | 1216 | | Van Slyke 1922 Download |
Jan 31, 2017 | 1217 | | Gokarn et al. 2006 Download |
Jan 31, 2017 | 1218 | | Gelfand 2006 Download |
Jan 31, 2017 | 1219 | | Fransson & Espander-Jansson 1996 Download |
Jan 31, 2017 | 1220 | | U.S. Pub. No. 2003/0138417 Download |
Jan 31, 2017 | 1221 | | Laursen et al. 2006 Download |
Jan 31, 2017 | 1222 | | Frenken et al. 1993 Download |
Jan 31, 2017 | 1223 | | Nozaki & Tanford 1967 Download |
Jan 31, 2017 | 1224 | | Olthuis et al. 1994 Download |
Jan 31, 2017 | 1225 | | GAMIMUNE Label (Oct. 2005) Download |
Jan 31, 2017 | 1226 | | Physicians Desk Reference (56th ed. 2002) Download |
Jan 31, 2017 | 1227 | | U.S. Prosecution History of App. No. 14/506,576 Download |
Jan 31, 2017 | 1228 | | U.S. Prosecution History of App. No. 13/774,735 - PART 1 of 2 Download |
Jan 31, 2017 | 1228 | | U.S. Prosecution History of App. No. 13/774,735 - PART 1 of 2 Download |
Jan 31, 2017 | 1228 | | U.S. Prosecution History of App. No. 13/774,735 - PART 2 of 2 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 3 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 4 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 6 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 1 of 6 Download |
Jan 31, 2017 | 1229 | | U.S. Prosecution History of App. No. 12/325,049 - PART 2 of 6 Download |
Jan 31, 2017 | 1230 | | U.S. Prosecution History of App. No. 61/004,992 Download |
Jan 31, 2017 | 1231 | | Stoner et al. 2004 Download |
Jan 31, 2017 | 1232 | | Fraunhofer Substantive Motion 3, Patent Interference No. 106,057 Download |
Jan 31, 2017 | 1233 | | Schwartz 2003 Download |
Jan 31, 2017 | 1234 | | U.S. Pub. No. 2004/0033535 Download |
Jan 31, 2017 | 1235 | | Gebhart 2001 Download |
Jan 31, 2017 | 1236 | | Carnahan et al. 2003 Download |
Jan 31, 2017 | 1237 | | Press Release (Jan. 23, 2003) Download |
Jan 31, 2017 | 1238 | | U.S. Pub. No. 2013/0273066 Download |
Jan 31, 2017 | 1239 | | U.S. Pub. No. 2012/0028877 Download |
Jan 31, 2017 | 1240 | | U.S. Pub. No. 2008/0311078 Download |
Jan 31, 2017 | 1241 | | WO 2006/138181, Gokarn et al. Download |
Jan 31, 2017 | 1242 | | U.S. Patent No. 6,090,382, Salfeld et al. Download |
Jan 31, 2017 | 1243 | | Gottlieb 2005 Download |
Jan 31, 2017 | 1244 | | Schwartzman & Morgan 2004 Download |
Jan 31, 2017 | 1245 | | Granolleras et al. 1991 Download |
Jan 31, 2017 | 1246 | | Development Pharmaceutics for Biotechnological and Biological Products (Oct. 21, 1999) Download |
Jan 31, 2017 | 1247 | | Clinical Pharmacology and Biopharmaceutics Review(s), Application No. 125057/0, in Approval Package for Humira (Approved Dec. 31, 2002) Download |
Jan 31, 2017 | 1248 | | Patent Owner's Preliminary Response, IPR2016-01018, Paper No. 9 Download |
Jan 31, 2017 | 1249 | | A Bioworld Special Report: Biosimilars: U.S. Market Opportunities and Critical Strategies 2016 Download |
Jan 31, 2017 | 1250 | | WO 1997/029131, Salfeld et al. Download |
Jan 31, 2017 | 1251 | | HUMIRA Label (Nov. 2015) Download |
Jan 31, 2017 | 1252 | | HUMIRA Label (Oct. 2016) Download |
Jan 31, 2017 | 1253 | | SYNAGIS Label (July 2004) Download |
Jan 31, 2017 | 1254 | | Vivaglobin Label (Jan. 2006) Download |
Jan 31, 2017 | 1255 | | CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) Download |
Jan 31, 2017 | 1256 | | GAMMAGARD LIQUID Label (April 2005) Download |
Jan 31, 2017 | 1257 | | OCTAGAM Label (Mar. 2004) Download |
Jan 31, 2017 | 1258 | | Flebogamma Label (Jan. 2004) Download |
Jan 31, 2017 | 1259 | | GAMUNEX Label (Nov. 2005) Download |
Jan 31, 2017 | 1260 | | Privigen Label (Oct. 2016) Download |
Jan 31, 2017 | 1261 | | HepaGam B Summary Basis for Approval (Jan. 2006) Download |
Jan 31, 2017 | 1262 | | AVASTIN Label (Feb. 2004) Download |
Jan 31, 2017 | 1263 | | TYSABRI Label (Nov. 2004) Download |
Jan 31, 2017 | 1264 | | Vectibix Label (Sept. 2006) Download |
Jan 31, 2017 | 1265 | | Campath Label (Aug. 2006) Download |
Jan 31, 2017 | 1266 | | Akers et al. 2002 Download |
Jan 31, 2017 | 1267 | | Cleland & Langer 1994 Download |
Jan 31, 2017 | 1268 | | Hanna (Mar. 10, 2003) Download |
Jan 31, 2017 | 1269 | | Handbook of Pharmaceutical Excipients (5th ed. 2006) Download |
Jan 31, 2017 | 1270 | | Note for Guidance on Development Pharmaceutics (Jan. 28, 1998) Download |
Jan 31, 2017 | 1271 | | Injection Tips (Archived Mar. 17, 2005) Download |
Jan 31, 2017 | 1272 | | Dean, Lange's Handbook of Chemistry (9th ed. 1999) Download |
Jan 31, 2017 | 1273 | | van de Putte, et al. (September 1998) Download |
Jan 31, 2017 | 1274 | | HUMIRA Label (Oct. 2005) Download |
Jan 31, 2017 | 1275 | | HUMIRA Label (Feb. 2008) Download |
Jan 31, 2017 | 1276 | | HUMIRA Label (Feb. 2007) Download |
Jan 31, 2017 | 1277 | | HUMIRA Label (Nov. 2006) Download |
Jan 31, 2017 | 1278 | | Meadows & Hollowell (2008) Download |
Jan 31, 2017 | 1279 | | ENBREL Label (Sept. 2002) Download |
Jan 31, 2017 | 1280 | | ENBREL Label (Nov. 1998) Download |
Jan 31, 2017 | 1281 | | REMICADE Label (Aug. 1998) Download |
Jan 31, 2017 | 1282 | | Tsourounis (June 2005) Download |
Jan 31, 2017 | 1283 | | U.S. Patent No. 6,696,056, Cheung et al. Download |
Jan 31, 2017 | 1284 | | Summary Review for Regulatory Action, Sarah Yim, Division of Pulmonary, Allergy, and Rheumatology Products (U.S. FDA), of Humira (2015) Download |
Jan 31, 2017 | 1285 | | Nash (2016) Download |